Axmedis logo  
 
login image img image with project title
 home
 overview
 objectives
 AXFramework
 downloads
 partners
 derived
   projects
 affiliation
 annual report
 links
 contacts
 statistics
 products
Your Comments and Questions

Search




Visitors:
  counter image
table cell background
.
Products
Axmedis @ IBC 2007 S


AXMEDIS automates your content management: production, protection for multichannel distribution and publication, internet, broadcast, P2P, mobile, etc.

The AXMEDIS allows you to reduce costs and increase efficiency. It provides support to automatize all the backoffice aspects (access to any CMSs and databases, processing, adaptation, fingerprinting, licensing, transcoding, MPEG-21, OMA, any metadata, metadata enrichment, reporting, accounting, etc.).

AXMEDIS supports the whole value chain and allows the convergence of the media and interoperability of content to enable multichannel distribution (e.g., mobile, satellite, kiosk, iTV, etc). AXMEDIS provides support for flexible and interoperable DRM, for B2B and B2C areas and for traditional and P2P distirbution platforms. AXMEDIS is offering MPEG-21 authoring tools and player tools PC, PDA, STB, PVR, HDR, Mobiles, MAC, etc. and all you need to automate your content management life cycle.

Main AXMEDIS products

  • AXMEDIS COPOP, content posting solution, to involve your final user, to collect their content and redistributing it for social networking or integrated it in your content based business solutions.

A selection of integrated solutions and experiences

In the following, a number of AXMEDIS based solutions from relevant international partners with their comments and appreciations:

Paolo Nesi, Ph.D.
Via S. Marta 3, 50139 Firenze, Italy
Email: nesi@dsi.unifi.it, paolo.nesi@unifi.it, p.nesi@computer.org
http://www.dsi.unifi.it/~nesi/


 



EU flag
 
 
 
newsletter



Valid HTML 4.0!

Valid CSS!

Level A conformance icon, 
			W3C-WAI Web Content Accessibility Guidelines 1.0

Disclaimer Notice:
"The content of this site is the sole responsibility of the AXMEDIS Consortium and in no way represents the views of the European Commission or its services."